|
MOCS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.00469995948316E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5655999999975E-05 |
| Normal-vs-Stage2 |
1.590340E-02 |
| Normal-vs-Stage3 |
3.305000E-03 |
| Normal-vs-Stage4 |
4.594300E-02 |
| Stage1-vs-Stage2 |
3.198000E-01 |
| Stage1-vs-Stage3 |
1.306190E-01 |
| Stage1-vs-Stage4 |
7.918200E-01 |
| Stage2-vs-Stage3 |
5.564200E-01 |
| Stage2-vs-Stage4 |
7.140800E-01 |
| Stage3-vs-Stage4 |
3.061000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02010000446739E-08 |
| Normal-vs-AfricanAmerican |
7.024000E-04 |
| Normal-vs-Asian |
4.458600E-01 |
| Caucasian-vs-AfricanAmerican |
7.755900E-02 |
| Caucasian-vs-Asian |
5.417800E-01 |
| AfricanAmerican-vs-Asian |
8.569200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.58210000445314E-08 |
| Normal-vs-Female |
1.63726999999891E-05 |
| Male-vs-Female |
3.740600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.339600E-03 |
| Normal-vs-Extreme_Weight |
5.237800E-04 |
| Normal-vs-Obese |
1.51123999999614E-05 |
| Normal-vs-Extreme_Obese |
1.409030E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.110400E-01 |
| Normal_Weight-vs-Obese |
5.462600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.617000E-01 |
| Extreme_Weight-vs-Obese |
8.652000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.261600E-01 |
| Obese-vs-Extreme_Obese |
3.179200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.561790E-03 |
| Normal-vs-Age(41-60Yrs) |
1.03099999648748E-08 |
| Normal-vs-Age(61-80Yrs) |
5.53650000000294E-05 |
| Normal-vs-Age(81-100Yrs) |
3.240400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.726000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.669700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.297800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.558400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.430100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.750400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.21619999959854E-07 |
| Normal-VS-Type2 PRCC |
5.645600E-04 |
| Normal-VS-KIRP CIMP |
1.821630E-01 |
| Normal-VS-Unclassified PRCC |
3.75620000000465E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.730800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.733000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.069800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.359000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.764300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.000400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.594200E-02 |
| Normal-vs-N1 |
3.049100E-04 |
| Normal-vs-N2 |
9.287800E-01 |
| N0-vs-N1 |
3.478200E-02 |
| N0-vs-N2 |
4.417800E-01 |
| N1-vs-N2 |
9.598300E-02 |
|
|
